Valuation Mayinglong Pharmaceutical Group Co., LTD.

Stocks

End-of-day quote Shanghai S.E. 30/09/2026			5-day change	1st Jan Change
22.52 ^CNY	+1.40%		+1.67%	-19.57%

08-25	Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-10	China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025	2026	2027	2028
Market Cap ¹	10,423	11,255	12,070	9,707	-	-
Change	-	7.98%	7.24%	-19.57%	-	-
Enterprise Value (EV)	10,423	11,255	12,070	9,707	9,707	9,707
Change	-	7.98%	7.24%	-19.57%	0%	0%
P/E	-	21.2x	20.7x	14.6x	13.1x	11.9x
PBR	-	2.77x	2.76x	2.04x	1.77x	1.53x
PEG	-	-	2.12x	1x	1.2x	1.1x
Capitalization / Revenue	3.32x	3.02x	3.12x	2.31x	2.11x	1.95x
EV / Revenue	0x	0x	0x	2.31x	2.11x	1.95x
EV / EBITDA	-	0x	0x	11.6x	10.5x	9.57x
EV / EBIT	-	0x	0x	12.1x	11x	9.96x
EV / FCF	-	0x	-	9.8x	9.64x	8.84x
FCF Yield	-	2.62%	-	10.2%	10.4%	11.3%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	1.23	1.35	1.545	1.715	1.9
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,137	3,728	3,867	4,198	4,606	4,980
EBITDA ¹	-	686.7	791.2	834	926.5	1,014
EBIT ¹	-	666.8	719.9	801	886.5	975
Net income ¹	443.3	528.1	581.5	667.5	739.5	819
Net Debt	-	-	-	-	-	-
Reference price ²	24.18	26.11	28.00	22.52	22.52	22.52
Nbr of stocks (in thousands)	431,054	431,054	431,054	431,054	-	-
Announcement Date	12/04/24	02/04/25	24/04/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MAYINGLONG PHARMACEUTICAL GROUP CO., LTD.	14.58x	-	-	-	1.45B
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.74x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	25.41x	6.52x	17.28x	2.29%	369.86B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%